Welcome to BioSeeker Group!

Global Cancer Focus Company Directory

Additional Information

Published Date Apr 30, 2007
Special Offer

You can deduct the full value of this report within 30 days of purchase towards a Cancer Highlights subscription.
Read more about becoming a Cancer Highlights subscriber here.

Pages 98
PDF Fact Sheet View Fact Sheet for the report Global Cancer Focus Company Directory in PDF
Format PDF
Publisher BioSeeker Group
Product Line View All Available Cancer Highlights Reports

Availability: In stock

$1,950.00

Quick Overview

Global Cancer Focus Company Directory pulls out virtually all cancer drug developing companies in the world. After several acquisitions and mergers in the market place, BioSeeker offers you the tool to get an updated look on the competitive landscape in oncology, including almost 900 hundred companies in 39 different countries.

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to Global Cancer Focus Company Directory.

    To find out more about Global Cancer Focus Company Directory, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that Global Cancer Focus Company Directory is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

Executive Summary

Global Cancer Focus Company Directory pulls out virtually all cancer drug developing companies in the world. After several acquisitions and mergers in the market place, BioSeeker offers you the tool to get an updated look on the competitive landscape in oncology, including almost 900 hundred companies in 39 different countries. Global Cancer Focus Company Directory breaks down all companies into their involvement in 81 different cancer indications, also including supportive care and diagnosis.

Global Cancer Focus Company Directory is a CD-ROM product with a 98 pages supplementary PDF included. The CD-ROM product is based on BioSeeker’s proprietary CD-ROM technology which includes smart database structure, find and sort options, internet and e-mail interactivity. Found information on the CD-ROM may easily be shared with others via file export (txt and xls), e-mail or print.

Each company profile reports on:

  • Cancer Focus (Includes 81 different cancer indications)
  • Year Founded
  • Ownership (Private/Public)
  • Contact details (Address, Phone, Fax, Web and E-mail)
  • A brief company description
  • All companies are provided with links, which connect you directly to the company webpage for further research. Companies can be further researched on from inside the application by linking search queries directly to search engines like Google and PubMed.

How May This Product Be of Use?

  • Comprehensive source of oncology companies
  • Find new and emerging companies in oncology
  • Find out your potential competitors, partners, M&A candidates etc. on a cancer indication specific level
  • Jump start competitive intelligence operations
  • Excellent starting point for world-wide benchmarking
  • Speed up pro-active in-/out-licensing strategy work
  • Track companies over time using search engines
  • Show investors/board/management that you are right on top of industry development

System Requirements

  • AMD-Athlon/Pentium II PC
  • Windows 98/NT4/2000/ME/XP/Vista
  • 8x-speed CD Rom drive
  • SVGA 16 bit display. (32 bit recommended)
  • 32 MB of available RAM (128 MB recommended)
  • Internet access (to test web-enabled presentations)

Executive Summary
Latest Acquisitions, Mergers and Bankruptcies in the Oncology Arena
New Emerging Oncology Companies
- 2007
- 2006
- 2005
- 2004
- 2003
Oncology Companies by Country
- Argentina
- Australia
- Austria
- Belgium
- Bermuda
- Brazil
- Canada
- China
- Croatia
- Cuba
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- India
- Ireland
- Israel
- Italy
- Japan
- New Zealand
- Norway
- Philippines
- Portugal
- Russia
- Singapore
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- United Kingdom
- USA
Companies by Cancer Indications
- Benign prostatic hyperplasia
- Cancer fatigue
- Cancer, basal cell
- Cancer, biliary
- Cancer, bladder
- Cancer, bone
- Cancer, brain
- Cancer, breast
- Cancer, carcinoid
- Cancer, carcinoid syndrome
- Cancer, cervical
- Cancer, CNS
- Cancer, colorectal
- Cancer, endometrial
- Cancer, esophageal
- Cancer, gastrointestinal, general
- Cancer, gastrointestinal, stomach
- Cancer, gastrointestinal, stromal
- Cancer, head and neck
- Cancer, leukemia, acute lymphocytic
- Cancer, leukemia, acute myelogenous
- Cancer, leukemia, chronic lymphocytic
- Cancer, leukemia, chronic myelogenous
- Cancer, leukemia, general
- Cancer, leukemia, hairy cell
- Cancer, liver
- Cancer, lung, general
- Cancer, lung, non-small cell
- Cancer, lung, small cell
- Cancer, lymphoma, B-cell
- Cancer, lymphoma, general
- Cancer, lymphoma, Hodgkin`s
- Cancer, lymphoma, non-Hodgkin`s
- Cancer, lymphoma, T-cell
- Cancer, melanoma
- Cancer, mesothelioma
- Cancer, myeloma
- Cancer, myeloma, multiple
- Cancer, myoma
- Cancer, nasopharyngeal
- Cancer, neuroendocrine
- Cancer, oesophageal
- Cancer, oral
- Cancer, ovarian
- Cancer, pancreatic
- Cancer, peritoneal
- Cancer, prostate
- Cancer, renal
- Cancer, renal, cell carcinoma
- Cancer, sarcoma, general
- Cancer, sarcoma, Kaposi`s
- Cancer, sarcoma, leiomyo
- Cancer, skin, general
- Cancer, solid tumor
- Cancer, squamous cell
- Cancer, testicular
- Cancer, therapy adjuvant
- Cancer, thyroid
- Chemotherapy-induced alopecia
- Chemotherapy-induced eczema
- Chemotherapy-induced infection
- Chemotherapy-induced injury, bone marrow, general
- Chemotherapy-induced injury, bone marrow, leucopenia
- Chemotherapy-induced injury, bone marrow, neutropenia
- Chemotherapy-induced injury, bone marrow, thrombocytopenia
- Chemotherapy-induced injury, general
- Chemotherapy-induced injury, GI
- Chemotherapy-induced injury, renal
- Chemotherapy-induced mucositis
- Chemotherapy-induced nausea and vomiting
- Diagnosis, cancer
- Dysplasia, anal
- Dysplasia, cervical
- Fibrocystic breast disorder
- Myelodysplastic syndrome
- Myelofibrosis, myeloid metaplasia
- Pain, cancer
Disclaimer
Liability
Completeness

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to Global Cancer Focus Company Directory.
    To find out more about Global Cancer Focus Company Directory, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that Global Cancer Focus Company Directory is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

Other selected research from the 'Cancer Highlights' category:


A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market
The colorectal cancer report part comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 investigators, from Ceased to Marketed. This part extensively analyses their 210 identified drug targets, organized into 205 drug target strategies, and assesses them in eight different compound strategies in colorectal cancer. Learn More


Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change is Around the Corner in a Highly Competitive Market Place
This report comprises defined and up to date development strategies for 405 breast cancer drugs within the portfolio of 220 investigators, from Ceased to Marketed. The report extensively analyses 207 identified targets of breast cancer drugs, organized into 193 drug target strategies, and assesses them in breast cancer. Significantly new breast cancer therapies will soon come to challenge old established drugs on the market. Learn More

Other selected research from the 'Oncology' category:


Target Atlas in Gastrointestinal Cancer: A Competitive Outlook
System Requirements - Operating system: Windows (2000/XP/Vista/7/8/10) and Mac OS X 10.6 (Snow Leopard) and OS X 10.7 (Lion)
- Browser Application (Internet Explorer)
- Internet access (to access related internet resources)
Learn More


Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Angiogenesis
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More